[Acute dangerous phases and terminal conditions in thyroid gland diseases].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D002118:Calcium / Q000378:metabolism; D003128:Coma / Q000188:drug therapy; D003401:Creatine / Q000378:metabolism; D004562:Electrocardiography; D004576:Electromyography; D005260:Female; D006801:Humans; D006934:Hypercalcemia; D006980:Hyperthyroidism / Q000175:diagnosis* / Q000628:therapy*; D007037:Hypothyroidism / Q000175:diagnosis*; D007455:Iodine / Q000627:therapeutic use; D007456:Iodine Isotopes / Q000627:therapeutic use; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use*; D008875:Middle Aged; D009230:Myxedema / Q000175:diagnosis; D011188:Potassium / Q000378:metabolism; D013610:Tachycardia; D013960:Thyroid Function Tests; D014882:Water-Electrolyte Balance
D007456:Iodine Isotopes; D008750:Methyldopa; D000324:Adrenocorticotropic Hormone; D007455:Iodine; D003401:Creatine; D011188:Potassium; D002118:Calcium
Akute gefahrvolle Phasen sowie Endzustände von Schilddrüsenerkrankungen.